trending Market Intelligence /marketintelligence/en/news-insights/trending/Jdc-sbYJQmjeBUiQgBw33Q2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Flu vaccines perform better in '18-'19; Chinese Ebola vaccine maker plans HK IPO

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Flu vaccines perform better in '18-'19; Chinese Ebola vaccine maker plans HK IPO

Here are the editors' top picks for the week ended March 22.

Hospital, doctor visits decline as vaccines perform better in '18-'19 flu season

Flu vaccines' effectiveness rates have implications for both healthcare providers and flu shot manufacturers, as shots that offer greater protection from the virus can mean less revenue for hospitals and more sales for vaccine-makers.

Chinese Ebola vaccine maker to IPO in Hong Kong

The CEO of Tianjin-based vaccine maker CanSino Biologics Inc. is betting his company can close the gap on vaccine manufacturing in China, where scandals in recent years have roiled the industry and created a crisis of confidence in the public sphere.

Biogen shares drop over 29% after Alzheimer's trial halt with Eisai

Analysts predicted that shares of Biogen Inc. could slide significantly today as the company's other pipeline prospects are few and commercial products face low growth potential.

New Hampshire's Medicaid work rules challenged in federal court

New Hampshire's Medicaid work requirements are being challenged in the U.S. District Court for the District of Columbia, making New Hampshire the third state facing a lawsuit for pursuing the controversial policy.

Of Mice Not Men: Promising sepsis remedy; lack of sleep linked to heart problems

Research into an experimental therapy for sepsis has shown that a drug being developed at the Royal College of Surgeons in Ireland has the potential to stop sepsis-causing bacteria from triggering organ damage.

Fentanyl overdose deaths spike in men, minorities; group seeks opioid moratorium

Overdose deaths from fentanyl have spiked in men, particularly in African-Americans and Hispanics, U.S. health officials reported. Meanwhile, a consumer watchdog called for a moratorium on the approval of new opioids in the midst of the epidemic.

Gottlieb confident US FDA being left in good shape, but regrets unfinished work

Departing U.S. Food and Drug Administration Commissioner Scott Gottlieb said he was confident he is leaving the agency in good shape, though he acknowledged some work he had hoped to tackle will be left unfinished.

Medicare adviser recommends 2.8% payment rate increase for acute care hospitals

In their March reports to Congress, a Medicare adviser recommends a 2.8% increase in acute care hospital payments and its counterpart for Medicaid recommends slowing down billions of dollars of long-delayed hospital cuts.

Cardiology Roundup: Apple's Watch heart study, Amarin's Vascepa follow-up

The American College of Cardiology meeting brought together more than 16,600 attendees, highlighting clinical trial results, cardiovascular device studies and large outcomes data from hundreds of thousands of patients.

Capitol Checkup: More drug pricing rounds; emerging diseases a perpetual threat

There was more activity on Capitol Hill last week aimed at lowering Americans' costs for prescription medicines; meanwhile, top health officials updated Capitol Hill on the U.S. response to the Ebola outbreak in the Democratic Republic of the Congo.